GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » Other Long Term Assets

Valneva SE (XBUL:AYJ) Other Long Term Assets : лв31.9 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Other Long Term Assets?

Valneva SE's other long-term assets for the quarter that ended in Dec. 2024 was лв31.9 Mil.

Valneva SE's quarterly other long-term assets increased from Jun. 2024 (лв31.0 Mil) to Sep. 2024 (лв36.8 Mil) but then stayed the same from Sep. 2024 (лв36.8 Mil) to Dec. 2024 (лв31.9 Mil).

Valneva SE's annual other long-term assets increased from Dec. 2022 (лв25.5 Mil) to Dec. 2023 (лв28.4 Mil) and increased from Dec. 2023 (лв28.4 Mil) to Dec. 2024 (лв31.9 Mil).

Valneva SE Other Long Term Assets Historical Data

The historical data trend for Valneva SE's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Other Long Term Assets Chart

Valneva SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.55 44.56 25.46 28.37 31.87

Valneva SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.37 29.57 31.03 36.80 31.87

Valneva SE Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » Other Long Term Assets
Comparable Companies
XPAR:MEDCL XPAR:ABVX XPAR:IVA XPAR:DBV XPAR:ALCLS XPAR:GNFT XPAR:IPH XPAR:NANO XPAR:OSE XPAR:MAAT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
VALN:USA INRLF:USA 0OB3:UK VLA:France AYJ:Germany VLA:Austria
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Website
https://www.valneva.com
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Valneva SE Headlines

No Headlines